Last viewed: CVKD


Prices are updated after-hours



nasdaq:CVKD Cadrenal Therapeutics, Inc.

CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |

(0.0% 1d) (-31.6% 1m) (-76.2% 1y) (0.0% 2d) (0.0% 3d) (-5.5% 7d) (21.8% volume)
Earnings Calendar:
Market Cap: $ 6,702,746


Sec Filling | Patents | n/a employees






add to watch list Paper trade email alert is off

Press-releases


Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024
Published: 2024-04-11 (Crawled : 21:00) - prnewswire.com
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: -5.3% H: 8.26% C: -0.05%

conference therapeutics growth
Zura Bio Announces Robert Lisicki as CEO and Director
Published: 2024-04-08 (Crawled : 11:00) - biospace.com/
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: 6.72% H: 0.0% C: -10.34%
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.48% H: 0.0% C: 0.0%

ceo
Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: -4.12% H: 5.84% C: 1.37%

update therapeutics
Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial
Published: 2024-02-08 (Crawled : 22:00) - biospace.com/
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: -14.15% H: 2.05% C: -6.2%

trial therapeutics
Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation Therapy for Patients with Certain Medical Conditions
Published: 2024-01-31 (Crawled : 15:30) - biospace.com/
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: -1.79% H: 12.12% C: 10.3%

publication medical therapeutics therapy
Cadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
Published: 2024-01-24 (Crawled : 14:30) - biospace.com/
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: 1.94% H: 16.98% C: 16.98%

conference therapeutics
Cadrenal Therapeutics Engages The Sage Group to Advance Tecarfarin's Late-Stage Development and Commercialization
Published: 2023-12-12 (Crawled : 21:00) - biospace.com/
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: 8.38% H: 3.13% C: -6.96%
PPRUF | News | $361.9 37.56% 4.3K twitter stocktwits trandingview |
Consumer Non-Durables
| | O: 3.3% H: 0.0% C: -2.63%
PPRUY | News | $36.03 -0.11% 330K twitter stocktwits trandingview |
Manufacturing
| | O: 0.88% H: 0.0% C: -0.52%

group commercialization therapeutics
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2023 Investor Conference
Published: 2023-10-09 (Crawled : 23:00) - biospace.com/
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: 2.78% H: 1.52% C: -4.63%

conference therapeutics
Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from the Recent European Society of Cardiology Congress
Published: 2023-09-05 (Crawled : 15:00) - biospace.com/
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: 7.74% H: 1.77% C: -9.38%

congress therapeutics cardiology
Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS)
Published: 2023-08-30 (Crawled : 14:00) - biospace.com/
CVKD | $0.4187 -0.71% -0.72% 160K twitter stocktwits trandingview |
| | O: 5.49% H: 0.0% C: -2.54%

therapeutics
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount
0001213900-24-031923 4 2024-04-10 2024-04-10 Sell G 50000 3275000


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
66% 34%

Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M twitter stocktwits trandingview |
Finance

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | $0.92 84.0% 45.65% 900K twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

ZCMD | $2.44 78.1% 43.85% 330K twitter stocktwits trandingview |
Commercial Services

XPON | $3.1 60.62% 37.74% 16M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Last 48 Hours Insiders Buying
AXR P 2400 | $22.17 2.69% 0.0% 5.5K twitter stocktwits trandingview |
Finance
| 21:00
FAST P 3350 | $67.5 -1.43% -1.45% 3.6M twitter stocktwits trandingview |
Distribution Services
| 20:00
QCRH | $55.405 1.33% 1.31% 54K twitter stocktwits trandingview |
Finance
| 18:01
RVP P 15363 | $1.05 0.96% 0.0% 120K twitter stocktwits trandingview |
Health Technology
| 18:00
VUZI | $1.26 3.28% 3.17% 1M twitter stocktwits trandingview |
Electronic Technology
| 18:00
TPL P 3 | $582.4 -0.44% 0.0% 63K twitter stocktwits trandingview |
Miscellaneous
| 15:00
RELL | $10.15 2.94% 2.86% 94K twitter stocktwits trandingview |
Electronic Technology
| 13:30
IZEA | $2.65 4.74% 4.53% 31K twitter stocktwits trandingview |
Technology Services
| 00:00
RKT P 383 | $11.53 1.32% 0.0% 1.6M twitter stocktwits trandingview |
Finance
| 22:30
CTRN P 18090 | $22.28 -0.4% -0.4% 55K twitter stocktwits trandingview |
Retail Trade
| 22:00
BRN P 10650 | $2.8 0.36% -0.36% 54K twitter stocktwits trandingview |
Energy Minerals
| 21:00
NEOG P 10000 | $11.94 -1.65% -1.68% 2.9M twitter stocktwits trandingview |
Health Technology
| 16:30
RMCF | $3.61 2.27% 2.22% 18K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar